Abraxane

Active Ingredient(s): Nanoparticle Albumin-Bound Paclitaxel
FDA Approved: * January 7, 2005
Pharm Company: * ABRAXIS BIOSCIENCE
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Abraxane Overview

Protein-bound paclitaxel, also known as nanoparticle albumin–bound paclitaxel or nab-paclitaxel, is an injectable formulation of paclitaxel used to treat breast cancer, lung cancer and pancreatic cancer, among others. Paclitaxel destroys cancer cells by preventing the normal breakdown of microtubules during cell division.[1][2][3] In this formulation, paclitaxel is bonded to albumin as a delivery vehicle.[4] It is manufact...

Read more Abraxane Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Protein-bound_paclitaxel

Recent Abraxane Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Nanoparticle Albumin-Bound Paclitaxel
  • For Suspension: 100mg/vial
  • Injection: 6mg/ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Abraxane: (1 result)

Sorted by National Drug Code
  • 68817-134 Abraxane 100 mg/20ml Intravenous Injection, Powder, Lyophilized, for Suspension by Abraxis Bioscience, LLC

Other drugs which contain Nanoparticle Albumin-Bound Paclitaxel or a similar ingredient: (6 results)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 15 December 2018.

We are committed to your privacy.

Copyright © 2005-2018 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA